Relationship of body composition with prevalence of osteoporosis in central south Chinese postmenopausal women (Q33757720)

29 July 2017

title

Relationship of body composition with prevalence of osteoporosis in central south Chinese postmenopausal women (English)

1 reference

29 July 2017

0 references

Zhifeng Sheng

1

1 reference

29 July 2017

Kang Xu

2

1 reference

29 July 2017

Yangna Ou

3

1 reference

29 July 2017

Ruchun Dai

4

1 reference

29 July 2017

Xianghang Luo

5

1 reference

29 July 2017

Shiping Liu

6

1 reference

29 July 2017

Xin Su

7

1 reference

29 July 2017

Xiyu Wu

8

1 reference

29 July 2017

Hui Xie

9

1 reference

29 July 2017

Lingqing Yuan

10

1 reference

29 July 2017

Eryuan Liao

11

1 reference

29 July 2017

publication date

1 March 2011

1 reference

29 July 2017

published in

Clinical Endocrinology

1 reference

29 July 2017

volume

74

1 reference

29 July 2017

issue

3

1 reference

29 July 2017

page(s)

319-324

1 reference

Relationships between fat and bone.

29 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2010.03941.X

Correlation of obesity and osteoporosis: effect of fat mass on the determination of osteoporosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2010.03941.X

Impact of lean mass and fat mass on bone mineral density: The Hordaland Health Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2010.03941.X

Relationship of obesity with osteoporosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2010.03941.X

Relationship between body composition and bone mineral density (BMD) in perimenopausal Korean women.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2010.03941.X

Body mass index as a predictor of fracture risk: a meta-analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2010.03941.X

Body size and hip fracture risk in older women: a prospective study. Study of Osteoporotic Fractures Research Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2010.03941.X

Prospective 10-year study of the determinants of bone density and bone loss in normal postmenopausal women, including the effect of hormone replacement therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2010.03941.X

Vertebral deformity in chinese men: prevalence, risk factors, bone mineral density, and body composition measurements

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2010.03941.X

Leptin stimulates human osteoblastic cell proliferation, de novo collagen synthesis, and mineralization: Impact on differentiation markers, apoptosis, and osteoclastic signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2010.03941.X

Relationship between body composition and bone mineral density in women with and without osteoporosis: relative contribution of lean and fat mass

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2010.03941.X

Establishment of BMD reference plots and determination of peak BMD at multiple skeletal regions in mainland Chinese women and the diagnosis of osteoporosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2010.03941.X

Community-based interventions to reduce overweight and obesity in China: a systematic review of the Chinese and English literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2010.03941.X

Contributions of lean mass and fat mass to bone mineral density: a study in postmenopausal women

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2010.03941.X

Effects of recombinant leptin therapy in a child with congenital leptin deficiency.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2010.03941.X

Beneficial effects of leptin on obesity, T cell hyporesponsiveness, and neuroendocrine/metabolic dysfunction of human congenital leptin deficiency.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2010.03941.X

Clinical practice. Postmenopausal hormone-replacement therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2010.03941.X

Obesity and sarcopenia after menopause are reversed by sex hormone replacement therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2010.03941.X

Leptin is expressed in and secreted from primary cultures of human osteoblasts and promotes bone mineralization

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2010.03941.X

Leptin acts as a growth factor on the chondrocytes of skeletal growth centers

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2010.03941.X

Leptin inhibits bone formation through a hypothalamic relay: a central control of bone mass

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2010.03941.X

Leptin regulates bone formation via the sympathetic nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2010.03941.X

Leptin directly regulates bone cell function in vitro and reduces bone fragility in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2010.03941.X

10.1111/J.1365-2265.2010.03941.X

21 January 2018

Identifiers

DOI

1 reference

29 July 2017

1 reference